| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.6 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.059 | 0.6 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.028 | 0.6 |